202 related articles for article (PubMed ID: 19655811)
1. Crystallographic analysis of bacterial signal peptidase in ternary complex with arylomycin A2 and a beta-sultam inhibitor.
Luo C; Roussel P; Dreier J; Page MG; Paetzel M
Biochemistry; 2009 Sep; 48(38):8976-84. PubMed ID: 19655811
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of a bacterial signal peptidase in complex with a beta-lactam inhibitor.
Paetzel M; Dalbey RE; Strynadka NC
Nature; 1998 Nov; 396(6707):186-90. PubMed ID: 9823901
[TBL] [Abstract][Full Text] [Related]
3. Crystallographic and biophysical analysis of a bacterial signal peptidase in complex with a lipopeptide-based inhibitor.
Paetzel M; Goodall JJ; Kania M; Dalbey RE; Page MG
J Biol Chem; 2004 Jul; 279(29):30781-90. PubMed ID: 15136583
[TBL] [Abstract][Full Text] [Related]
4. Common protein architecture and binding sites in proteases utilizing a Ser/Lys dyad mechanism.
Paetzel M; Strynadka NC
Protein Sci; 1999 Nov; 8(11):2533-6. PubMed ID: 10595561
[TBL] [Abstract][Full Text] [Related]
5. Structural and initial biological analysis of synthetic arylomycin A2.
Roberts TC; Smith PA; Cirz RT; Romesberg FE
J Am Chem Soc; 2007 Dec; 129(51):15830-8. PubMed ID: 18052061
[TBL] [Abstract][Full Text] [Related]
6. Computational alanine scanning and free energy decomposition for E. coli type I signal peptidase with lipopeptide inhibitor complex.
Li T; Froeyen M; Herdewijn P
J Mol Graph Model; 2008 Jan; 26(5):813-23. PubMed ID: 17532654
[TBL] [Abstract][Full Text] [Related]
7. [Novel inhibitors against the bacterial signal peptidase I].
Liao GJ; He Y; Xie JP
Yao Xue Xue Bao; 2012 Dec; 47(12):1561-6. PubMed ID: 23460958
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a bacterial signal Peptide peptidase.
Kim AC; Oliver DC; Paetzel M
J Mol Biol; 2008 Feb; 376(2):352-66. PubMed ID: 18164727
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide.
Lu D; Fütterer K; Korolev S; Zheng X; Tan K; Waksman G; Sadler JE
J Mol Biol; 1999 Sep; 292(2):361-73. PubMed ID: 10493881
[TBL] [Abstract][Full Text] [Related]
10. The effects of mutations in the carboxyl-terminal region on the catalytic activity of Escherichia coli signal peptidase I.
Kim YT; Yoshida H; Kojima M; Kurita R; Nishii W; Muramatsu T; Ito H; Park SJ; Takahashi K
J Biochem; 2008 Feb; 143(2):237-42. PubMed ID: 18032415
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic investigation of the Staphylococcus aureus type I signal peptidase SpsB - implications for the search for novel antibiotics.
Rao S; Bockstael K; Nath S; Engelborghs Y; Anné J; Geukens N
FEBS J; 2009 Jun; 276(12):3222-34. PubMed ID: 19438721
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of a bacterial signal peptidase apoenzyme: implications for signal peptide binding and the Ser-Lys dyad mechanism.
Paetzel M; Dalbey RE; Strynadka NC
J Biol Chem; 2002 Mar; 277(11):9512-9. PubMed ID: 11741964
[TBL] [Abstract][Full Text] [Related]
13. Regulation of signal peptidase by phospholipids in membrane: characterization of phospholipid bilayer incorporated Escherichia coli signal peptidase.
Wang Y; Bruckner R; Stein RL
Biochemistry; 2004 Jan; 43(1):265-70. PubMed ID: 14705954
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of type I bacterial signal peptidase: Biological consequences and therapeutic potential.
Craney A; Romesberg FE
Bioorg Med Chem Lett; 2015 Nov; 25(21):4761-4766. PubMed ID: 26276537
[TBL] [Abstract][Full Text] [Related]
15. The extended interactions and Gla domain of blood coagulation factor Xa.
Wang SX; Hur E; Sousa CA; Brinen L; Slivka EJ; Fletterick RJ
Biochemistry; 2003 Jul; 42(26):7959-66. PubMed ID: 12834348
[TBL] [Abstract][Full Text] [Related]
16. A small subset of signal peptidase residues are perturbed by signal peptide binding.
Musial-Siwek M; Yeagle PL; Kendall DA
Chem Biol Drug Des; 2008 Aug; 72(2):140-6. PubMed ID: 18637988
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence spectroscopy of soluble E. coli SPase I Δ2-75 reveals conformational changes in response to ligand binding.
Bhanu MK; Kendall DA
Proteins; 2014 Apr; 82(4):596-606. PubMed ID: 24115229
[TBL] [Abstract][Full Text] [Related]
18. Development of an internally quenched fluorescent substrate and a continuous fluorimetric assay for Streptococcus pneumoniae signal peptidase I.
Peng SB; Zheng F; Angleton EL; Smiley D; Carpenter J; Scott JE
Anal Biochem; 2001 Jun; 293(1):88-95. PubMed ID: 11373083
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into the non-additivity effects in the sequence-to-reactivity algorithm for serine peptidases and their inhibitors.
Lee TW; Qasim MA; Laskowski M; James MN
J Mol Biol; 2007 Mar; 367(2):527-46. PubMed ID: 17266986
[TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations.
Smith PA; Roberts TC; Romesberg FE
Chem Biol; 2010 Nov; 17(11):1223-31. PubMed ID: 21095572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
